VANCOUVER, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Sunniva Inc. (“Sunniva”, the “Company”, “we”,
“our” or “us”) (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and
services, announces that Daniel Vass has tendered his resignation as President of Natural Health Services Ltd. (“NHS”), a
wholly owned subsidiary of the Company, effective immediately.
Mr. Vass also resigned as director of the Company effective immediately.
Dr. Anthony Holler, Chairman and CEO, commented: "We thank Dan for his contribution to the Company over the
past two years and wish him well in his future endeavors. The Company will ensure that the necessary plans are put in place
to effect a smooth transition."
In order to ensure continuity going forward, Dr. Mark Kimmins, Medical Director of NHS, will take over day to
day management of NHS in the interim. The Company will begin a search for a replacement and no changes in its goals or objectives
are planned in the short term.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the
policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis
markets – Canada and California. Our ability to leverage our large-scale, purpose-built cGMP designed greenhouses, offering
better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe,
high quality products at scale. Through our strategically positioned cultivation and extraction facilities, we are launching
Sunniva branded products in various product categories including flower, pre-rolls, beverages, vape cartridges, extracts as well as
aggressively pursuing upstream vertical opportunities including distribution and retail expansion. Sunniva's management and board
of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech
industries.
About Natural Health Services Ltd. (“NHS”)
NHS owns and operates a network of seven clinics in Canada specializing in medical cannabis under the Cannabis Act
(Canada). NHS connects patients with safe and effective medical cannabis products through Licenced Producers. NHS has
in-house physicians and nurse practitioners specializing in the endocannabinoid system providing expert consultation, education,
and recommendations for patients. NHS’ proprietary technology infrastructure assists physicians, patients and LPs to comply with
the rules of Health Canada. NHS currently has approximately 105,000 registered patients.
Company Contact:
Dr. Anthony Holler
Chairman and Chief Executive Officer
Phone: (866) 786-6482
Investor Contact:
Phil Carlson / Erika Kay
KCSA Strategic Communications
Phone: (212) 896-1233
Email: pcarlson@kcsa.com / ekay@kcsa.com
Media Contact:
Katelyn Tumino
KCSA Strategic Communications
Phone: (212) 896-1252
Email: ktumino@kcsa.com
